Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Has results × Smoking × Budesonide × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Smoking 1 Small Cell Lung Carcinoma 1 Lung Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1 Breast Neoplasms 1

Interventions

Tobacco Use Cessation Devices 2 zileuton 1 olaparib 1 Vitamin B 12 1 Varenicline 1 Radiotherapy 1 Patient Navigation 1 Nicotine Replacement Therapy 1 Folic Acid 1 Erlotinib Hydrochloride 1 Cycloserine 1 Cetuximab 1 Celecoxib 1 Budesonide 1 10-propargyl-10-deazaaminopterin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00321893 2016-01-25

Budesonide in Treating Patients With Lung Nodules at High Risk of Developing Lung Cancer

National Cancer Institute (NCI)

Phase 2 Completed

225 enrolled 10 charts

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Smoking, Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡